Literature DB >> 8331087

Neuraminic acid is alpha 2-->3 linked in the lipooligosaccharide of Neisseria meningitidis serogroup B strain 6275.

R Yamasaki1, J M Griffiss, K P Quinn, R E Mandrell.   

Abstract

We have analyzed the sialylated lipooligosaccharide of Neisseria meningitidis 6275. Sialylated oligosaccharide released from strain 6275 lipooligosaccharide by mild hydrolysis was determined to contain N-acetylneuraminic acid linked alpha 2-->3 to terminal galactose as shown below. [formula: see text]

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8331087      PMCID: PMC204901          DOI: 10.1128/jb.175.14.4565-4568.1993

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  12 in total

1.  Epitope expression of gonococcal lipooligosaccharide (LOS). Importance of the lipoidal moiety for expression of an epitope that exists in the oligosaccharide moiety of LOS.

Authors:  R Yamasaki; H Schneider; J M Griffiss; R Mandrell
Journal:  Mol Immunol       Date:  1988-08       Impact factor: 4.407

2.  Endogenous sialylation of the lipooligosaccharides of Neisseria meningitidis.

Authors:  R E Mandrell; J J Kim; C M John; B W Gibson; J V Sugai; M A Apicella; J M Griffiss; R Yamasaki
Journal:  J Bacteriol       Date:  1991-05       Impact factor: 3.490

3.  Growth of Neisseria gonorrhoeae in CMP-N-acetylneuraminic acid inhibits nonopsonic (opacity-associated outer membrane protein-mediated) interactions with human neutrophils.

Authors:  R F Rest; J V Frangipane
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

4.  Structural determination of oligosaccharides derived from lipooligosaccharide of Neisseria gonorrhoeae F62 by chemical, enzymatic, and two-dimensional NMR methods.

Authors:  R Yamasaki; B E Bacon; W Nasholds; H Schneider; J M Griffiss
Journal:  Biochemistry       Date:  1991-10-29       Impact factor: 3.162

5.  Sialylation and human neutrophil killing of group C Neisseria meningitidis.

Authors:  M M Estabrook; N C Christopher; J M Griffiss; C J Baker; R E Mandrell
Journal:  J Infect Dis       Date:  1992-11       Impact factor: 5.226

6.  Factors affecting expression of glycolipid tumor antigens: influence of ceramide composition and coexisting glycolipid on the antigenicity of gangliotriaosylceramide in murine lymphoma cells.

Authors:  R Kannagi; R Stroup; N A Cochran; D L Urdal; W W Young; S Hakomori
Journal:  Cancer Res       Date:  1983-10       Impact factor: 12.701

7.  Cytidine 5'-monophospho-N-acetylneuraminic acid or a related compound is the low Mr factor from human red blood cells which induces gonococcal resistance to killing by human serum.

Authors:  C A Nairn; J A Cole; P V Patel; N J Parsons; J E Fox; H Smith
Journal:  J Gen Microbiol       Date:  1988-12

8.  Cytidine 5'-monophospho-N-acetyl neuraminic acid and a low molecular weight factor from human blood cells induce lipopolysaccharide alteration in gonococci when conferring resistance to killing by human serum.

Authors:  N J Parsons; P V Patel; E L Tan; J R Andrade; C A Nairn; M Goldner; J A Cole; H Smith
Journal:  Microb Pathog       Date:  1988-10       Impact factor: 3.738

9.  In vitro and in vivo modification of Neisseria gonorrhoeae lipooligosaccharide epitope structure by sialylation.

Authors:  R E Mandrell; A J Lesse; J V Sugai; M Shero; J M Griffiss; J A Cole; N J Parsons; H Smith; S A Morse; M A Apicella
Journal:  J Exp Med       Date:  1990-05-01       Impact factor: 14.307

10.  Lipooligosaccharides (LOS) of Neisseria gonorrhoeae and Neisseria meningitidis have components that are immunochemically similar to precursors of human blood group antigens. Carbohydrate sequence specificity of the mouse monoclonal antibodies that recognize crossreacting antigens on LOS and human erythrocytes.

Authors:  R E Mandrell; J M Griffiss; B A Macher
Journal:  J Exp Med       Date:  1988-07-01       Impact factor: 14.307

View more
  15 in total

1.  Sialylation of Neisseria meningitidis lipooligosaccharide inhibits serum bactericidal activity by masking lacto-N-neotetraose.

Authors:  M M Estabrook; J M Griffiss; G A Jarvis
Journal:  Infect Immun       Date:  1997-11       Impact factor: 3.441

2.  The lipooligosaccharides of Haemophilus ducreyi are highly sialylated.

Authors:  W Melaugh; A A Campagnari; B W Gibson
Journal:  J Bacteriol       Date:  1996-01       Impact factor: 3.490

3.  Expression of sialic acid and polysialic acid in serogroup B Neisseria meningitidis: divergent transcription of biosynthesis and transport operons through a common promoter region.

Authors:  J S Swartley; J H Ahn; L J Liu; C M Kahler; D S Stephens
Journal:  J Bacteriol       Date:  1996-07       Impact factor: 3.490

4.  Lipooligosaccharide structure contributes to multiple steps in the virulence of Neisseria meningitidis.

Authors:  Laura Plant; Johanna Sundqvist; Susu Zughaier; Lena Lövkvist; David S Stephens; Ann-Beth Jonsson
Journal:  Infect Immun       Date:  2006-02       Impact factor: 3.441

5.  Anti-Gal binds to pili of Neisseria meningitidis: the immunoglobulin A isotype blocks complement-mediated killing.

Authors:  R M Hamadeh; M M Estabrook; P Zhou; G A Jarvis; J M Griffiss
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

6.  Identification of the gonococcal glmU gene encoding the enzyme N-acetylglucosamine 1-phosphate uridyltransferase involved in the synthesis of UDP-GlcNAc.

Authors:  J Ullrich; J P van Putten
Journal:  J Bacteriol       Date:  1995-12       Impact factor: 3.490

7.  The (alpha2-->8)-linked polysialic acid capsule and lipooligosaccharide structure both contribute to the ability of serogroup B Neisseria meningitidis to resist the bactericidal activity of normal human serum.

Authors:  C M Kahler; L E Martin; G C Shih; M M Rahman; R W Carlson; D S Stephens
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

8.  Analysis of C3 deposition and degradation on Neisseria meningitidis and Neisseria gonorrhoeae.

Authors:  G A Jarvis
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

Review 9.  Current status of meningococcal group B vaccine candidates: capsular or noncapsular?

Authors:  J Diaz Romero; I M Outschoorn
Journal:  Clin Microbiol Rev       Date:  1994-10       Impact factor: 26.132

10.  Monoclonal antibodies against Haemophilus lipopolysaccharides: clone DP8 specific for Haemophilus ducreyi and clone DH24 binding to lacto-N-neotetraose.

Authors:  S Borrelli; E L Roggen; D Hendriksen; J Jonasson; H J Ahmed; P Piot; P E Jansson; A A Lindberg
Journal:  Infect Immun       Date:  1995-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.